Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 9:30 pm Sale |
2024-12-04 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital Management LLC | 2,548,905 5.000% |
-1,522,949 (-37.40%) |
Filing History |
| 2024-11-19 9:31 pm Sale |
2024-11-15 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital Management LLC | 4,071,854 7.700% |
-914,461 (-18.34%) |
Filing History |
| 2024-11-19 09:57 am Unchanged |
2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital Management LLC | 1,020,052 2.800% |
0 (Unchanged) |
Filing History |
| 2024-11-18 9:57 pm Purchase |
2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital Management LLC | 1,020,052 2.800% |
1,020,052 (New Position) |
Filing History |
| 2024-11-07 9:35 pm Unchanged |
2024-11-06 | 13D | Tango Therapeutics, Inc. TNGX |
Boxer Capital Management LLC | 6,988,450 6.500% |
0 (Unchanged) |
Filing History |
| 2024-10-28 09:22 am Purchase |
2024-10-25 | 13D | Tango Therapeutics, Inc. TNGX |
Boxer Capital Management LLC | 6,988,450 6.500% |
6,988,450 (New Position) |
Filing History |
| 2024-10-25 9:48 pm Purchase |
2024-10-10 | 13G | uniQure N.V. QURE |
Boxer Capital Management LLC | 2,225,000 4.600% |
2,225,000 (New Position) |
Filing History |
| 2024-10-25 9:46 pm Purchase |
2024-10-10 | 13G | SpringWorks Therapeutics, Inc. SWTX |
Boxer Capital Management LLC | 3,421,541 4.600% |
3,421,541 (New Position) |
Filing History |
| 2024-10-25 9:44 pm Purchase |
2024-10-10 | 13G | Nkarta, Inc. NKTX |
Boxer Capital Management LLC | 3,443,606 4.900% |
3,443,606 (New Position) |
Filing History |
| 2024-10-25 9:42 pm Purchase |
2024-10-10 | 13G | Instil Bio, Inc. TIL |
Boxer Capital Management LLC | 355,500 5.500% |
355,500 (New Position) |
Filing History |
| 2024-10-25 9:39 pm Purchase |
2024-10-10 | 13G | Century Therapeutics, Inc. IPSC |
Boxer Capital Management LLC | 3,174,603 3.700% |
3,174,603 (New Position) |
Filing History |
| 2024-10-25 9:37 pm Purchase |
2024-10-10 | 13G | Fate Therapeutics, Inc. FATE |
Boxer Capital Management LLC | 4,960,910 4.400% |
4,960,910 (New Position) |
Filing History |
| 2024-10-22 9:15 pm Purchase |
2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital Management LLC | 4,986,315 9.900% |
4,986,315 (New Position) |
Filing History |